Cite
HARVARD Citation
Kurmasheva, R. et al. (2018). Initial testing (stage 1) of M6620 (formerly VX‐970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program. Pediatric blood & cancer. 65 (2), p. n/a. [Online].